2022-05-09 | NDAQ:ACIU | Press Release : comparemela.com

(2022-05-09 | NDAQ:ACIU) AC Immune's Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology

Related Keywords

Massachusetts , United States , Switzerland , Immuneresponseandalzheimer Closecurlyquote , Gary Waanders , Saoyuth Nidh , Ashani Lewis , Eli Lilly , Parkinson Closecurlyquote , Corey Davis , Michael Rafii , Down Syndrome Foundation , Genentech , Barrow Neurological Institute , National Institutes Of Health , National Institute On , Janssen Pharmaceuticals Inc , Brain Communications , Exchange Commission , Disease Cooperative Study , University Of California San Diego , Company Closecurlyquote , Roche Group , Securities Exchange , Therapeutic Research Institute , Alzheimer Closecurlyquote , Keck School , Southern California , Medical Director , Massachusetts General Hospital , California San Diego , National Institute , National Institutes , Diseases Conference , Adults With Down Syndrome , Randomized Clinical Trial , Hatchet Man , Alzheimer Disease , Janssen Pharmaceuticals , Securities Act , Securities Exchange Act , Risk Factors Closecurlydoublequote , Financial Review , Prospects Closecurlydoublequote , Annual Report , Ac Immune Sa , Healthcare 37 , Biotechnology 121 , Usa 8 , Biotechnology 70569 ,